Brokerage Reports
XOMA Corporation [XOMA]
Reports for Purchase
Showing records 141 - 160 ( 331 total )
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
Phase 2 Trial of XOMA 358 in Congenital Hyperinsulinism Initiated; Reiterate OUTPERFORM and $6 Price Target
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 25.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
October and 2015 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
October and 2015 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
Novartis Deal Provides Cash to Progress The Pipeline; Reiterate OUTPERFORM But Reducing PT
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 25.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
September and 2015 Catalysts for Emerging PharmaceuticalsThis report contains brief updates on the following: BIOD, BMRN, CBYL, ICPT, LXRX, OMER, PCRX, RGLS, RLYP, SGMO, UTHR, VTAE, XOMA. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
Emerging Pharmaceuticals: September and 2015 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
Q2:15 Update; Endocrine Portfolio Now Center Stage; Reiterate OUTPERFORM but Reducing Price Target to $11 Due to Pipeline Refocus
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 25.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
August and 2015 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
EYEGUARD-Bummer Is NOT Game Over for Xoma. Reiterate OUTPERFORM but Reducing our PT to $13.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 25.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 20
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 10.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
July and 2015 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of June 29
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 10.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
XOMA 358 Receives Orphan Drug Designation for the Treatment of Congenital Hyperinsulinism; Reiterate OUTPERFORM and $17 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 10.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
Emerging Pharmaceuticals - June and 2015 Catalysts for Emerging Pharmaceuticals
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
FINALLY! The Last Exacerbation in EYEGUARD-B Has Occurred; We Anticipate Positive Topline Results in July; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 10.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
Q1:15 Update; One Event Away from EYEGUARD-B Completion; Reiterate OUTPERFORM and $17 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 25.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
May and 2015 Emerging Pharmaceuticals Catalysts
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
May and 2015 Emerging Pharmaceuticals Catalysts
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 50.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of April 6th
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 10.00
Company: XOMA Corporation
Industry: Medical - Biomedical and Genetics
April and 2015 Emerging Pharmaceuticals CatalystsThis report contains brief updates on the following: BIOD, BMRN, ICPT, LXRX, OMER, RCPT, RLYP, SGMO, VTAE, XOMA. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Price: 100.00